BIOKÉ Webshop

Forgot password?Login

No need to login to view prices!

No account?

Enjoy the advantages of a BIOKÉ webshop account.

Invalid login

Your credentials are incorrect or you are trying to login with a non-existing webshop account. Our website shows product prices without login! Therefore webshop accounts that were only used to view prices have been deleted.

Please create a new account with your shipping and billing details if you would like to be able to order or view your discount.


Webshop under construction

The BIOKÉ webshop is closed until 14:00 January 2nd, 2020. We wish you a successful 2020!

Forgot your password?

Don't worry. Enter your username and we will send you a link to reset your password if an associated user is found.

Need help?

Have trouble resetting your password? Contact us and we will help you.

You've got mail

You will receive an e-mail containing a link to start the recovery procedure within minutes.


Change password

Change your password to something secure.

Success

Your password has been changed.


Password sent

You will receive an e-mail from us containing your new password in the coming minutes.

Please change your password to something memorable and secure upon logging in.


Welcome

Sign out

Explore more effective viral CPE assays for virology and vaccine research

 

Download the Vaccine & Virology Handbook to discover a more efficient method to quantitatively characterize viral samples

Developing novel methods to screen antivirals is important for creating broad-spectrum anti-viral drugs and vaccines. The accurate measurement of viral activity plays an essential role for viral vaccine development and infectious disease studies. Find out why the rapid, sensitive, and high throughput xCELLigence Real-Time Cell Analysis Assay is ideal for infectious viral assays.

Download Handbook

 

Applications in the Vaccine & Virology Handbook include:

  • Viral Titer Determination
  • Detection and Quantification of Neutralizing Antibodies
  • Studying Anti-viral Drugs
  • Testing Virucides
  • Oncolytic Viruses
  • Assessing virus quality/fitness


Say Goodbye to Endpoint Assays:

Conventional methods to measure virus and neutralizing antibody titers such as plaque assays, plaque reduction neutralization tests (PRNT), immunofluorescence foci assays (IFA), or interferon CPE assays are:

  • Labor intensive
  • Time consuming
  • Difficult to reproduce
  • No assessment or quantification of the full virus life cycle.
  • Wrong timepoint can result in inaccurate calculation of viral titer and lytic activity

 

Conventional endpoint assays are labor intensive, time consuming, and difficult to reproduce, since different cell types and cell densities, as well as viral strains, serotypes, and mutations can cause plaque formation rates and sizes to vary dramatically.

Endpoint assays do not provide an assessment or quantification of the full virus life cycle.

Suboptimal selection of a single assay endpoint can result in inaccurate calculation of viral titer and lytic activity.

 

 

High throughput and Simple Workflow

 

Example data for key virology/vaccine applications


Receive your digital copy of this handbook

Product has been added to your cart.